Skip to content

Prevalence, Clinical Features, and Prognosis of Coronary Artery Embolism With Concomitant Atrial Fibrillation

Prevalence, Clinical Features, and Prognosis of Coronary Artery Embolism With Concomitant Atrial Fibrillation

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06845956
Enrollment
5163
Registered
2025-02-25
Start date
2024-05-01
Completion date
2024-12-31
Last updated
2025-02-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Myocardial Infarction Type 2, Coronary Artery Embolism

Keywords

coronary artery ebolism, acute myocardial infarction, atrial fibrillation

Brief summary

The goal of this observational study is to learn about the Prevalence, Clinical Features, and Prognosis of Coronary Artery Embolism With Concomitant Atrial Fibrillation. The main question it aims to answer is: What is the proportion of coronary artery embolism with concomitant atrial fibrillation among all myocardial infarctions and myocardial infarctions with concomitant atrial fibrillation? What are the clinical characteristics of coronary artery embolism with concomitant atrial fibrillation? What is the prognosis of coronary artery embolism with concomitant atrial fibrillation? All participants will receive routine diagnosis and treatment, and baseline demographic data, clinical examination laboratory results, and follow-up data will be collected for analysis.

Detailed description

The study is designed as an observational study without involving experimental drugs or device interventions, only collecting data from routine medical practice. Importance: Atrial fibrillation (AF) and acute myocardial infarction (AMI) share common risk factors and interact pathophysiologically. Coronary embolism (CE) is a critical mechanism of AMI in AF patients, yet its clinical features and prognosis remain understudied. Objective: To investigate the incidence, clinical characteristics, and prognosis of CE in patients with AF. Design, Setting, and Participants: A single-center retrospective case-control study was conducted at the Affiliated First Hospital of Ningbo University, China. Patients diagnosed with AMI who underwent coronary angiography (CAG) between January 1, 2014, and December 31, 2023, were included. CE was diagnosed using the Shibata criteria. Participants were categorized into three groups: AF-related CE, non-CE AF with AMI, and AMI without AF. Main Outcomes and Measures: Baseline characteristics, clinical features, coronary involvement, treatment strategies, and outcomes (all-cause mortality, cardiac-death mortality, major adverse cardiovascular and cerebrovascular events \[MACCE\], recurrent embolism, and major bleeding) were compared.

Interventions

OTHERIs it coronary artery embolism

This observational study categorizes patients with acute myocardial infarction (AMI) into three distinct groups based on their clinical characteristics: 1. Group 1: Patients with atrial fibrillation (AF) and coronary artery embolism (CAE). 2. Group 2: Patients with AF but non-coronary artery embolism myocardial infarction (non-CAE MI). 3. Group 3: Patients without AF and non-coronary artery embolism myocardial infarction (non-CAE MI without AF). A key innovation of this study compared to previous research is its expanded eligibility criteria for AMI patients. Earlier studies typically focused exclusively on ST-segment elevation myocardial infarction (STEMI). In contrast, this investigation encompasses a broader spectrum of acute myocardial infarction, including both STEMI and non-ST-segment elevation myocardial infarction (NSTEMI). This comprehensive approach enhances the generalizability and applicability of the findings by capturing a wider range of clinical scenarios.

Sponsors

First Affiliated Hospital of Ningbo University
Lead SponsorNETWORK

Study design

Observational model
CASE_CONTROL
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Clinical diagnosis of Acute myocardial infarction * Selective coronary angiography has been performed.

Exclusion criteria

* Clinical diagnosis of Iatrogenic coronary artery embolism * Clinical diagnosis of Coronary artery dilation * Clinical diagnosis of Coronary in-stent thrombosis and embolism * Clinical diagnosis of Coronary slow flow syndrome * Clinical diagnosis of Coronary artery dissection * Clinical diagnosis of Coronary artery spasm * Pathological examination showed that the embolus contained atherosclerotic plaque * Endovascular imaging examinations, including intravascular ultrasound (IVUS) and optical coherence tomography (OCT), indicate the presence of plaque rupture, erosion, or ulceration in the culprit vessel. * Clinical diagnosis of Previous myocardial infarction * Previous coronary stent implantation or coronary artery bypass surgery.

Design outcomes

Primary

MeasureTime frameDescription
All-cause death, cardiogenic deathUp to 10 years
Major Adverse Cardiovascular and Cerebrovascular EventsUp to 10 years
Systemic thrombo-embolismUp to 10 yearsBrain embolism, lower extremity arterial embolism, mesenteric arterial embolism, coronary artery embolism, splenic embolism, renal embolism.
Major hemorrhageUp to 10 yearsBARC Grades 3-5 Bleeding

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 30, 2026